VENARSEN
Report of the Council on Pharmacy and Chemistry
The report which appears below was sent to the Intravenous Products Company for consideration. Having considered the firm’s reply, the Council has authorized publication of its report along with the explanation sent by the Intravenous Products Company in reference to the variable composition reported for Venarsen, namely, that “only the first few experimental ampules, sent to the doctors for clinical tests, were made without the Mercuric Iodide.”
W. A. Puckner, Secretary.
This product is prepared by the Intravenous Products Company, Denver. The advertising circulars contain inconsistent statements as to its composition. According to one circular Venarsen is
“... a comparatively non-toxic organic arsenic compound, 0.6 Gm. representing 247 Mg. (33⁄4 grains) of metallic arsenic in chemical combination....”
According to another circular Venarsen is
“... a comparatively non-toxic organic arsenic compound, 0.6 Gm., representing 247 Mg. (33⁄4 grains) of metallic arsenic and .78 Mg. (3⁄250 grain) metallic mercury in chemical combination.”